- HK$14.27bn
- HK$15.71bn
- CNY7.82bn
- 87
- 77
- 14
- 66
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | PRESS | PRESS |
Standards: | IFRS | IFRS | IFRS | — | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 5,318 | 5,588 | 6,382 | 6,866 | 7,816 |
Cost of Revenue | |||||
Gross Profit | 4,393 | 4,525 | 5,276 | 5,672 | 6,642 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3,975 | 4,497 | 4,410 | 4,449 | 5,595 |
Operating Profit | 1,344 | 1,091 | 1,972 | 2,417 | 2,221 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 1,223 | 979 | 1,869 | 2,280 | 1,978 |
Provision for Income Taxes | |||||
Net Income After Taxes | 980 | 771 | 1,628 | 1,909 | 1,586 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 974 | 836 | 1,651 | 1,916 | 1,549 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 974 | 836 | 1,651 | 1,969 | 1,525 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.385 | 0.353 | 0.605 | 0.821 | 0.609 |
Dividends per Share |